Nancy E. Denyes - 21 May 2021 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Role
General Counsel
Signature
Nancy Denyes
Issuer symbol
ATYR
Transactions as of
21 May 2021
Net transactions value
$0
Form type
4
Filing time
25 May 2021, 21:06:08 UTC
Next filing
07 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LIFE Common stock 3,091 21 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Employee Stock Option (Right to buy) Award $0 +59,000 $0.000000 59,000 21 May 2021 Common Stock 59,000 $4.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 178 shares acquired under that Company's 2015 Employee Stock Purchase Plan on May 17, 2021.
F2 The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.